Turoctocog alfa pegol

Red

Brand Name(s):Esperoct

Indication:Treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia A (congenital factor VIII deficiency).

Rationale:1,2,3

Considered:Sep-20

Review Date:Sep-25

Comments:
Licensed for the treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia A (congenital factor VIII deficiency).
This is an NHS-England commisioned product.